| scholarly article | Q13442814 |
| P2093 | author name string | Gary L Davis | |
| P2860 | cites work | Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group | Q29620719 |
| Future options for the management of hepatitis C. | Q33647729 | ||
| Current therapy for chronic hepatitis C. | Q33951473 | ||
| Treatment of acute and chronic hepatitis C. | Q35960898 | ||
| Interferon treatment of viral hepatitis in immunocompromised patients | Q38210607 | ||
| Current Concepts in the Diagnosis and Management of Hepatitis B Surface Antigen-Positive Chronic Active Hepatitis | Q40102934 | ||
| Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features | Q40133889 | ||
| Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection | Q40439317 | ||
| Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial | Q41839327 | ||
| Genomic variation of hepatitis C virus: clues to clinical variation? | Q42983169 | ||
| Effect of Interferoh α and Ribavirin Therapy on Serum GB Virus C/Hepatiti G Virus (GBV‐C/HGV) RNA Levels in Patients Chronical Infected with Hepatitis C Virus and GBV‐C/HGV | Q42984020 | ||
| Hepatitis C virus genotypes and quasispecies | Q42997081 | ||
| Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders | Q42997948 | ||
| Detection of hepatitis C virus RNA genome in liver tissue by nonisotopic in situ hybridization | Q43035810 | ||
| Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. | Q43041128 | ||
| Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group | Q43046635 | ||
| Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients | Q43049083 | ||
| Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. | Q43049490 | ||
| Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation. | Q43831138 | ||
| Interferon in viral hepatitis: role in pathogenesis and treatment | Q44001359 | ||
| Hepatitis non A, non B. Manifestations and implications of acute and chronic disease | Q44450976 | ||
| Hepatitis C virus infection in kidney transplant recipients | Q45786651 | ||
| Spontaneous reactivation of chronic hepatitis B virus infection. | Q45794787 | ||
| Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon | Q45795541 | ||
| Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis | Q45828278 | ||
| Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis | Q46733463 | ||
| Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. | Q50586455 | ||
| Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group | Q50587547 | ||
| Estimates of the Cost-Effectiveness of a Single Course of Interferon-α2b in Patients with Histologically Mild Chronic Hepatitis C | Q52249518 | ||
| Treatment of chronic hepatitis C in active drug users | Q53479050 | ||
| Prolonged treatment with interferon in patients with histologically mild chronic hepatitis C: a decision analysis | Q58622887 | ||
| Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis | Q70233290 | ||
| Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group | Q71494730 | ||
| The incidental focal liver lesion: Photon, proton, or needle? | Q74530366 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 73-84 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Baylor University Medical Center Proceedings | Q26842047 |
| P1476 | title | Gary L. Davis, MD: a conversation with the editor. Interview by William Clifford Roberts | |
| P478 | volume | 16 |
| Q44367448 | The Effect of Telephone Consultation on the Quality of Life of Patients Receiving Interferon Therapy: A Quasi-experimental Study | cites work | P2860 |
Search more.